{"id":4547,"date":"2018-04-04T08:57:37","date_gmt":"2018-04-04T15:57:37","guid":{"rendered":"http:\/\/dev4.amneal.com\/dev.php7-30.phx1-1.websitetestlink.com\/?page_id=4547"},"modified":"2022-10-19T09:58:52","modified_gmt":"2022-10-19T16:58:52","slug":"executive-leadership","status":"publish","type":"page","link":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/","title":{"rendered":"Executive Leadership"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_accordion admin_label=&#8221;Executives&#8221; _builder_version=&#8221;3.0.84&#8243;] [et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Paul M. Bisaro Executive Chairman&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>Paul most recently served as President and Chief Executive Officer and a member of the Impax Laboratories Board of Directors since March 2017. \u00a0He is an accomplished global business leader with 25+ years of generic and branded pharmaceutical experience, and an exceptional track record of driving operational execution and corporate transformation resulting in company growth. He previously served as Executive Chairman of Allergan, plc (formerly Actavis, plc), President and CEO of Actavis (formerly Watson Pharmaceuticals, Inc.) and Chairman of the Board. Prior to joining then Watson in 2007, Paul was President, Chief Operating Officer and a member of the Board of Directors of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company (Barr), from 1999 to 2007. Between 1992 and 1999, Paul served as General Counsel of Barr, and from 1997 to 1999, served in various additional capacities. Prior to joining Barr, he was associated with the law firm Winston &amp; Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds, from 1989 to 1992. He also served as a Senior Consultant with Arthur Andersen &amp; Co. Paul currently serves on the Board of Directors of Allergan, Zoetis, Inc. and on the Board of Visitors of the Catholic University of America&#8217;s Columbus School of Law. He also served as Chairman of the Board of the Generic Pharmaceutical Association (GPhA, now Association of Accessible Medicines [AAM]) in 2010 and 2011. He received his undergraduate degree in General Studies from the University of Michigan and a Juris Doctor from Catholic University of America in Washington, D.C.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Robert Stewart President and Chief Executive Officer&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Rob most recently served as Chief Operating Officer of Allergan plc. He has 22 years of experience in global brand and generic pharmaceutical leadership, with expertise in all aspects of operations and integration. Prior to his appointment as Chief Operating Officer of Allergan in May 2016, Rob served as President, Generics and Global Operations from March 2015 to May 2016; Chief Operating Officer from July 2014 to March 2015; and President, Global Operations, from August 2010 to July 2014. He joined Allergan (then Watson) in November 2009 as Senior Vice President, Global Operations. Before joining Watson, Rob held various positions with Abbott Laboratories, Inc. from 1995 until 2009, and Hoffman La-Roche Inc. Rob has been a board member of the National Association of Manufacturers (NAM) since September 2016, and a member of the Fairleigh Dickinson University Board of Trustees since June 2017. He earned his Bachelor&#8217;s degree in Business Management and Finance from Fairleigh Dickinson University.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Andrew S. Boyer Executive Vice President, Commercial Operations&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Andy most recently served as President and CEO of North America Generics, Teva Pharmaceuticals, Inc.\u00a0 Prior to joining Teva, Andy was Senior Vice President of Sales and Marketing for the U.S. Generics Division at Allergan plc (formerly, Actavis plc; formerly, Watson Pharmaceuticals, Inc.) since September 2006. He joined then Watson in 1998 as Associate Director of Marketing in Generics. Before joining Watson, Andy served as National Accounts Manager for Lederle\/American Cyanamid as well as Marketing Manager for Barr Laboratories. He serves as a Director of the Association for Accessible Medicines. Andy received his Bachelor&#8217;s degree in Business Administration and Management from State University of New York at Albany.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Scott L. Hunter Vice President, Specialty Sales and Marketing&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Scott oversees Sales and Marketing for Amneal\u2019s Specialty Pharma business, operating under the Impax Specialty Pharma division. He is an accomplished sales and marketing leader with over 35 years of industry experience. Prior to joining Impax in 2012, Scott served as the principle in a consulting company specializing in learning and development for biopharmaceutical companies.\u00a0 Scott also held senior level positions at Schwarz Pharma USA, Millennium Pharmaceuticals, Inc. (now part of Takeda) and Wyeth (acquired by Pfizer). Scott received his Bachelor of Arts in Biochemistry from the University of Louisville.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Nikita Shah Senior Vice President, Chief Human Resources Officer &#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Nikita oversees human resources for Amneal.\u00a0 Prior to joining Amneal, Nikita led the internal audit and human resources functions for Warner Chilcott, a global specialty pharmaceutical company. She also supported corporate M&amp;A, process improvements and systems efficiencies across the organization. Prior to Warner Chilcott, Nikita held roles of increasing responsibilities at AT&amp;T and Deloitte Consulting.\u00a0 Nikita received her master\u2019s degrees in accounting and auditing from Gujarat University, India. She is a certified public accountant.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Open Senior Vice President, Technical Operations&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Dr. Shankar Hariharan Executive Vice President, Chief Scientific Officer &#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Dr. Hariharan oversees Research &amp; Development, Regulatory Affairs, and Specialty Pharmaceutical Dosage Development.\u00a0 Dr. Hariharan has over 30 years of experience in successfully leading branded and generic pharmaceutical businesses and has held leadership positions at companies including International Development Research, Forest Labs, and Par Pharmaceuticals. Prior to joining Amneal, Dr. Hariharan founded DermAct, an R&amp;D organization specializing in dermatology.\u00a0 Dr. Hariharan completed his bachelor\u2019s degree in pharmacy at Banaras Hindu University in India and his doctorate in pharmacy at Northeastern University in Boston, Massachusetts.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Dr. Suneel Gupta Senior Vice President, Chief Scientific Officer Specialty Products &#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Dr. Gupta oversees R&amp;D activities for Amneal\u2019s Specialty Pharma business, operating under the Impax Specialty Pharma division. Most recently, he served as Chief Scientific Officer at Impax, a role he held since February 2008. Prior his tenure at Impax, he served as Senior Vice President, R&amp;D at Johnson and Johnson. During his nearly 20-years at ALZA\/Johnson and Johnson, Dr. Gupta held several leadership roles of increasing where he made significant contributions to\u00a0the development of several drug delivery based products across several\u00a0therapeutic areas. His primary research focuses on the influence of rate and route of drug delivery\u00a0to discover new indications, maximize clinical utility and\/or effectiveness. He is credited as\u00a0the co-inventor and\/or developer of several drug delivery based clinically differentiated products. Before ALZA, Dr. Gupta was with Ciba Geigy (India) in pharmaceutical manufacturing. He received his\u00a0Ph.D. in Clinical Pharmacology from University of Manchester and Post-Doc from University of California, San Francisco. Dr.\u00a0Gupta is a co-author on more than 200 research publications and co-inventor on more than 40\u00a0patents.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Bryan M. Reasons Senior Vice President, Finance and Chief Financial Officer&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Bryan serves as Senior Vice President, Finance and Chief Financial Officer. Prior to joining Impax in 2012, Bryan served as Vice President, Finance and as Vice President, Risk Management and General Auditor, at Cephalon, Inc., a biopharmaceutical company. Following the acquisition of Cephalon by Teva Pharmaceutical Industries Ltd., he served as Vice President, Finance of Teva. Prior to joining Cephalon, Bryan held various financial management positions at DuPont and served as senior manager at PricewaterhouseCoopers LLP. He has a Bachelor\u2019s degree in accounting from Pennsylvania State University and a Master of Business Administration from Widener University and is a certified public accountant.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Sheldon Hirt Senior Vice President, General Counsel&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Sheldon is responsible for all legal and corporate governance matters and has more than 20 years of experience in corporate law. Most recently, Sheldon served as Executive Vice President and General Counsel for Progenics Pharmaceuticals, overseeing all legal and compliance matters for the company. Previous to Progenics, he was Senior Vice president and Assistant General Counsel at Allergan where he worked on major acquisitions, licensing and development collaborations, and strategic investments such as the acquisitions\/integration of Actavis, Forest Laboratories, and Warner Chilcott. Sheldon also held various leadership positions at Barr Laboratories, Johnson &amp; Johnson and also spent several years in private law practice.\u00a0 He served as an infantry officer in the United States Marine Corps and received his bachelor\u2019s degree from Columbia College in New York and his master\u2019s degree from Columbia University School of International and Public Affairs. He completed his juris doctor degree at Columbia Law School.<\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Deborah M. Penza Senior Vice President, Chief Compliance Officer&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;]<\/p>\n<p>Deborah joined Impax in 2015 as Senior Vice President, Chief Compliance Officer. She has more than 20 years of experience as both a consultant and a compliance professional implementing and operating compliance programs in the healthcare industry. Prior to joining Impax, she was with Actavis (formerly Watson Pharmaceuticals, Inc.) as the Company\u2019s Chief Compliance Officer. Prior to Actavis, Deborah served as the Vice President, Corporate Compliance for Elan Corporation, plc, where she led the company\u2019s global ethics and compliance program. Before joining Elan, she was a Vice President of Strategic Management Systems, Inc., where she developed and implemented compliance programs for healthcare clients and provided guidance on compliance program management. She received her Juris Doctorate from the George Mason University School of Law, and received a Master of Arts from The George Washington University. Deborah received her Bachelor\u2019s degree from Florida Atlantic University.<\/p>\n<p>[\/et_pb_accordion_item] [\/et_pb_accordion][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_accordion admin_label=&#8221;Executives&#8221; _builder_version=&#8221;3.0.84&#8243;] [et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Paul M. Bisaro Executive Chairman&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;] &nbsp; Paul most recently served as President and Chief Executive Officer and a member of the Impax Laboratories Board of Directors since March 2017. \u00a0He [&hellip;]<\/p>\n","protected":false},"author":26,"featured_media":11378,"parent":23,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-executive-leadership.php","meta":{"inline_featured_image":false},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Executive Leadership - Amneal Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Executive Leadership - Amneal Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"[et_pb_section bb_built=&#8221;1&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_accordion admin_label=&#8221;Executives&#8221; _builder_version=&#8221;3.0.84&#8243;] [et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Paul M. Bisaro Executive Chairman&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;] &nbsp; Paul most recently served as President and Chief Executive Officer and a member of the Impax Laboratories Board of Directors since March 2017. \u00a0He [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/\" \/>\n<meta property=\"og:site_name\" content=\"Amneal Pharmaceuticals\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-19T16:58:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/amneal.com\/wp-content\/uploads\/2021\/11\/amneal-about-executive-leadership.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1225\" \/>\n\t<meta property=\"og:image:height\" content=\"550\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/amneal.com\/#website\",\"url\":\"https:\/\/amneal.com\/\",\"name\":\"Amneal Pharmaceuticals\",\"description\":\"Amneal has quickly grown to become a formidable player in the generics industry through strategic acquisitions and significant investments in research, manufacturing and distribution capabilities.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/amneal.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#primaryimage\",\"url\":\"https:\/\/amneal.com\/wp-content\/uploads\/2021\/11\/amneal-about-executive-leadership.jpg\",\"contentUrl\":\"https:\/\/amneal.com\/wp-content\/uploads\/2021\/11\/amneal-about-executive-leadership.jpg\",\"width\":1225,\"height\":550},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/\",\"url\":\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/\",\"name\":\"Executive Leadership - Amneal Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\/\/amneal.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#primaryimage\"},\"datePublished\":\"2018-04-04T15:57:37+00:00\",\"dateModified\":\"2022-10-19T16:58:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/amneal.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"About\",\"item\":\"https:\/\/amneal.com\/about\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Our Leadership\",\"item\":\"https:\/\/amneal.com\/about\/our-leadership\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Executive Leadership\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Executive Leadership - Amneal Pharmaceuticals","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/","og_locale":"en_US","og_type":"article","og_title":"Executive Leadership - Amneal Pharmaceuticals","og_description":"[et_pb_section bb_built=&#8221;1&#8243;][et_pb_row][et_pb_column type=&#8221;4_4&#8243;][et_pb_accordion admin_label=&#8221;Executives&#8221; _builder_version=&#8221;3.0.84&#8243;] [et_pb_accordion_item _builder_version=&#8221;3.0.84&#8243; title=&#8221;Paul M. Bisaro Executive Chairman&#8221; use_background_color_gradient=&#8221;off&#8221; background_color_gradient_start=&#8221;#2b87da&#8221; background_color_gradient_end=&#8221;#29c4a9&#8243; background_color_gradient_type=&#8221;linear&#8221; background_color_gradient_direction=&#8221;180deg&#8221; background_color_gradient_direction_radial=&#8221;center&#8221; background_color_gradient_start_position=&#8221;0%&#8221; background_color_gradient_end_position=&#8221;100%&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; background_size=&#8221;cover&#8221; background_position=&#8221;center&#8221; background_repeat=&#8221;no-repeat&#8221; background_blend=&#8221;normal&#8221; allow_player_pause=&#8221;off&#8221; box_shadow_style=&#8221;none&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.3)&#8221; box_shadow_position=&#8221;outer&#8221;] &nbsp; Paul most recently served as President and Chief Executive Officer and a member of the Impax Laboratories Board of Directors since March 2017. \u00a0He [&hellip;]","og_url":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/","og_site_name":"Amneal Pharmaceuticals","article_modified_time":"2022-10-19T16:58:52+00:00","og_image":[{"width":1225,"height":550,"url":"https:\/\/amneal.com\/wp-content\/uploads\/2021\/11\/amneal-about-executive-leadership.jpg","type":"image\/jpeg"}],"twitter_card":"summary","twitter_misc":{"Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/amneal.com\/#website","url":"https:\/\/amneal.com\/","name":"Amneal Pharmaceuticals","description":"Amneal has quickly grown to become a formidable player in the generics industry through strategic acquisitions and significant investments in research, manufacturing and distribution capabilities.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amneal.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#primaryimage","url":"https:\/\/amneal.com\/wp-content\/uploads\/2021\/11\/amneal-about-executive-leadership.jpg","contentUrl":"https:\/\/amneal.com\/wp-content\/uploads\/2021\/11\/amneal-about-executive-leadership.jpg","width":1225,"height":550},{"@type":"WebPage","@id":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/","url":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/","name":"Executive Leadership - Amneal Pharmaceuticals","isPartOf":{"@id":"https:\/\/amneal.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#primaryimage"},"datePublished":"2018-04-04T15:57:37+00:00","dateModified":"2022-10-19T16:58:52+00:00","breadcrumb":{"@id":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/amneal.com\/about\/our-leadership\/executive-leadership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amneal.com\/"},{"@type":"ListItem","position":2,"name":"About","item":"https:\/\/amneal.com\/about\/"},{"@type":"ListItem","position":3,"name":"Our Leadership","item":"https:\/\/amneal.com\/about\/our-leadership\/"},{"@type":"ListItem","position":4,"name":"Executive Leadership"}]}]}},"_links":{"self":[{"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/pages\/4547"}],"collection":[{"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/comments?post=4547"}],"version-history":[{"count":78,"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/pages\/4547\/revisions"}],"predecessor-version":[{"id":12650,"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/pages\/4547\/revisions\/12650"}],"up":[{"embeddable":true,"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/pages\/23"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/media\/11378"}],"wp:attachment":[{"href":"https:\/\/amneal.com\/wp-json\/wp\/v2\/media?parent=4547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}